Thomas Kimber

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

Stephen M. Davis, Geoffrey A. Donnan, Mark Parsons et al. · The Lancet Neurology · 2008 · 1K citations

Thrombosis, Placebo-controlled Randomised Trial, Interventional Neuroradiology +12

Refining the Perfusion–Diffusion Mismatch Hypothesis

Kenneth Butcher, Mark Parsons, Lachlan MacGregor et al. · Stroke · 2005 · 222 citations

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

Angelo Antonini, Werner Poewe, К. Ray Chaudhuri et al. · Parkinsonism & Related Disorders · 2017 · 206 citations · Full text

Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques

Pierre Amarenco, Stephen M. Davis, E. Jones et al. · Stroke · 2014 · 195 citations · Full text

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

Michael J. Soileau, Jason Aldred, Kumar Budur et al. · The Lancet Neurology · 2022 · 172 citations

Advanced Parkinson, Parkinson Disease, Neurology +3